• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

New Medical-Grade UV Device Can Kill COVID Virus in 2 Seconds

by Fred Pennic 09/23/2020 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
New Medical-Grade UV Device Can Kill COVID Virus in 2 Seconds

What You Should Know:

– Innovators’ “NuvaWave™” launches a medical-grade, intelligent handheld UVC device that can kill the SARS-CoV-2, the virus that causes COVID-19 in two seconds.

– Initially, the founders created it for hospitals but it’s going on the market for commercial use – offices, gyms, hotels, airlines, voting booths – everywhere it’s needed so we can get back to life.


UV Innovators, an ultraviolet technology company has unveiled NuvaWave, one of the most advanced tool in the fight against deadly pathogens. NuvaWave is a UVC handheld device that is used to disinfect any high touch surface. This product release is timely as all businesses, schools, municipalities, airlines, cruise ships and other commercial ventures need to have a solution to protect their employees, students, customers, and family from COVID-19. 

NuvaWave Development

Initially, the founders created it for hospitals but it’s going on the market for commercial use – offices, gyms, hotels, airlines, voting booths – everywhere it’s needed so we can get back to life. NuvaWave was tested at Texas Biomed, an independent, nonprofit research institute whose mission is to protect our global community from the threats of infectious diseases through cutting-edge research. The results from the rigorous study completed at Texas Biomedical Research Institute demonstrated that NuvaWave killed >99.9% of the live virus in just two seconds.

For nearly three-quarters of a century, the Institute has delivered high quality and reliable scientific data, spanning basic discovery through preclinical development,” explained Dr. Cory Hallam, Professor and Vice President for Business Development at Texas Biomed. “The scientists at Texas Biomed know how to handle the live virus in their biosafety level 3 (BSL-3) lab and to use protocols to safely mimic real-world conditions that helped us document the effectiveness of NuvaWave,” added Dr. Nicholas Medendorp, CEO of UV Innovators. “NuvaWave .

New Medical-Grade UV Device Can Kill COVID Virus in 2 Seconds

NuvaWave handheld device only weighs 1.5 pounds and provides 5,000 hours of disinfection.  UV Innovators’ break-through technology changes the paradigm in making hospital-grade technology affordable. UV Innovators is announcing the NuvaWave Fleet Program starting at $199 a month that enables infection control teams a simple and affordable monthly payment.

Key Features

– Distance feedback to aid user in optimal placement

– Continuous system performance monitoring

– Embedded computer sensors for intelligent safety shut-off

– Uniform UVC light across disinfection area

– Ergonomically balanced design

– Visible light indicators of active disinfection

Why It Matters

“In order for people to feel comfortable getting back to normal, they must feel confident that the places they go are clean and free from infectious pathogens. NuvaWave is a commercial-grade solution for those who are disinfecting high-touch surfaces,” added Dr. Nicholas Medendorp, Jr., a technology leader with over two decades of LED experience and 115 patents and CEO of UV Innovators. “NuvaWave has undergone rigorous testing with accredited third-party laboratories to gauge its efficacy in killing SARS-CoV-2, the virus that causes COVID-19.,” added Dr. Medendorp.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Coronavirus (COVID-19), Patents, sensors

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |